Share Price and Basic Stock Data
Last Updated: November 28, 2025, 8:47 am
| PEG Ratio | 9.02 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Marico Ltd operates in the Edible Oils and Solvent Extraction industry, with a current market capitalization of ₹97,131 Cr and a share price of ₹748. The company’s revenue from operations has shown a steady upward trajectory, with a reported sales figure of ₹9,764 Cr for the fiscal year ending March 2023, which increased to ₹10,831 Cr for March 2025. The trailing twelve months (TTM) revenue stood at ₹12,265 Cr, indicating robust growth. Quarterly sales figures also reflect a positive trend, with the most recent quarter ending June 2025 reporting sales of ₹3,259 Cr, compared to ₹2,558 Cr in June 2022. This consistent growth trajectory is attributed to strategic initiatives and a strong brand portfolio that includes well-known products in personal care and food segments. The company’s operating profit margin (OPM) for March 2025 was reported at 20%, maintaining a competitive edge within the sector.
Profitability and Efficiency Metrics
Marico’s profitability metrics are solid, underscored by a net profit of ₹1,696 Cr for the fiscal year ending March 2025, demonstrating an increase from ₹1,322 Cr in the previous year. The reported return on equity (ROE) stood at a remarkable 41.3%, while return on capital employed (ROCE) was noted at 45.2%, indicating efficient use of capital. The company’s operating profit rose to ₹2,139 Cr for March 2025, with OPM remaining consistently above 20% over recent years. Other efficiency metrics, such as the cash conversion cycle (CCC), reported at 33 days, reflect Marico’s effective management of working capital. The interest coverage ratio (ICR) of 44.28x further illustrates the company’s ability to meet its interest obligations comfortably, highlighting financial stability relative to its peers in the industry.
Balance Sheet Strength and Financial Ratios
Marico’s balance sheet exhibits significant strength, with total reserves amounting to ₹3,846 Cr and borrowings of only ₹554 Cr, resulting in a low debt-to-equity ratio of 0.09, which is favorable compared to industry averages. The company’s current ratio stood at 2.07, indicating strong liquidity, while the quick ratio of 1.56 suggests sufficient short-term assets to cover current liabilities. Additionally, the price-to-book value (P/BV) ratio was reported at 21.15x, reflecting market confidence in the stock despite higher valuations. The company’s asset turnover ratio of 1.37 indicates effective utilization of assets to generate revenue. These financial ratios highlight Marico’s solid foundation and prudent financial management practices, positioning it favorably for future growth.
Shareholding Pattern and Investor Confidence
Marico’s shareholding pattern reveals a diverse investor base, with promoters holding 58.94% of the equity as of September 2025. Foreign institutional investors (FIIs) accounted for 24.21%, while domestic institutional investors (DIIs) held 11.88%. The public ownership stood at 4.58%, with a total of 289,152 shareholders. This distribution indicates a balanced mix of long-term and institutional investors, contributing to stable share price performance. The slight decline in promoter holding from 59.48% in December 2022 to the current figure reflects a marginal dilution but also suggests potential for increased institutional interest. The consistent dividend payout ratio, which was reported at 27.80% for March 2025, further underscores the company’s commitment to returning value to shareholders, enhancing investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Marico’s growth prospects appear promising, bolstered by its strong brand positioning and continuous product innovation. However, risks such as fluctuating raw material prices, regulatory challenges, and intense competition within the edible oils and personal care segments could pose significant challenges. The company needs to navigate these risks effectively to maintain its growth trajectory. Additionally, while the low debt levels present a strength, reliance on external financing for expansion could introduce volatility. Overall, Marico’s robust financial health and operational efficiency, coupled with a commitment to shareholder returns, position it well for future opportunities, contingent upon its ability to address market challenges effectively and sustain its competitive advantage.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Marico Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IEL Ltd | 103 Cr. | 7.90 | 10.3/3.87 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 315 Cr. | 1.68 | 4.40/1.52 | 221 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 64.6 Cr. | 2.71 | 4.90/1.45 | 25.1 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,725 Cr. | 1,331 | 3,633/321 | 1,835 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| BCL Industries Ltd | 1,016 Cr. | 34.4 | 57.8/33.0 | 9.76 | 28.9 | 0.75 % | 13.2 % | 13.0 % | 1.00 |
| Industry Average | 10,481.00 Cr | 167.09 | 152.38 | 33.77 | 0.18% | 14.09% | 12.05% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,558 | 2,496 | 2,470 | 2,240 | 2,477 | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,259 |
| Expenses | 2,030 | 2,063 | 2,014 | 1,847 | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,604 |
| Operating Profit | 528 | 433 | 456 | 393 | 574 | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 |
| OPM % | 21% | 17% | 18% | 18% | 23% | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% |
| Other Income | 17 | 19 | 40 | 68 | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 |
| Interest | 10 | 15 | 14 | 17 | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 |
| Depreciation | 36 | 37 | 39 | 43 | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 |
| Profit before tax | 499 | 400 | 443 | 401 | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 |
| Tax % | 24% | 23% | 25% | 24% | 23% | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% |
| Net Profit | 377 | 307 | 333 | 305 | 436 | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 |
| EPS in Rs | 2.87 | 2.33 | 2.54 | 2.34 | 3.30 | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 |
Last Updated: August 20, 2025, 7:10 am
Below is a detailed analysis of the quarterly data for Marico Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,259.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,730.00 Cr. (Mar 2025) to 3,259.00 Cr., marking an increase of 529.00 Cr..
- For Expenses, as of Jun 2025, the value is 2,604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,272.00 Cr. (Mar 2025) to 2,604.00 Cr., marking an increase of 332.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 655.00 Cr.. The value appears strong and on an upward trend. It has increased from 458.00 Cr. (Mar 2025) to 655.00 Cr., marking an increase of 197.00 Cr..
- For OPM %, as of Jun 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Mar 2025) to 20.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 56.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 45.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 52.00 Cr. (Mar 2025) to 45.00 Cr., marking a decrease of 7.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 656.00 Cr.. The value appears strong and on an upward trend. It has increased from 441.00 Cr. (Mar 2025) to 656.00 Cr., marking an increase of 215.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00%.
- For Net Profit, as of Jun 2025, the value is 513.00 Cr.. The value appears strong and on an upward trend. It has increased from 345.00 Cr. (Mar 2025) to 513.00 Cr., marking an increase of 168.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.89. The value appears strong and on an upward trend. It has increased from 2.65 (Mar 2025) to 3.89, marking an increase of 1.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,687 | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 12,265 |
| Expenses | 3,939 | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 10,059 |
| Operating Profit | 748 | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,206 |
| OPM % | 16% | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 18% |
| Other Income | 58 | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 194 |
| Interest | 34 | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 47 |
| Depreciation | 77 | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 188 |
| Profit before tax | 695 | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,165 |
| Tax % | 27% | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | |
| Net Profit | 504 | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,696 |
| EPS in Rs | 3.76 | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 12.86 |
| Dividend Payout % | 46% | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.07% | 23.59% | 12.17% | 1.97% | 36.76% | -7.78% | 14.96% | 4.67% | 5.34% | 13.62% | 10.39% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7.52% | -11.42% | -10.20% | 34.79% | -44.54% | 22.74% | -10.29% | 0.67% | 8.28% | -3.23% |
Marico Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: July 25, 2025, 2:47 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 |
| Reserves | 1,296 | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 |
| Borrowings | 680 | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 |
| Other Liabilities | 925 | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,752 |
| Total Liabilities | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 |
| Fixed Assets | 888 | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 |
| CWIP | 4 | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 |
| Investments | 311 | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 |
| Other Assets | 1,762 | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,893 |
| Total Assets | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 |
Below is a detailed analysis of the balance sheet data for Marico Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 129.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 129.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,846.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,703.00 Cr. (Mar 2024) to 3,846.00 Cr., marking an increase of 143.00 Cr..
- For Borrowings, as of Mar 2025, the value is 554.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 528.00 Cr. (Mar 2024) to 554.00 Cr., marking an increase of 26.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,752.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,993.00 Cr. (Mar 2024) to 3,752.00 Cr., marking an increase of 759.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 8,281.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,353.00 Cr. (Mar 2024) to 8,281.00 Cr., marking an increase of 928.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,758.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,724.00 Cr. (Mar 2024) to 2,758.00 Cr., marking an increase of 34.00 Cr..
- For CWIP, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 1,590.00 Cr.. The value appears strong and on an upward trend. It has increased from 602.00 Cr. (Mar 2024) to 1,590.00 Cr., marking an increase of 988.00 Cr..
- For Other Assets, as of Mar 2025, the value is 3,893.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,983.00 Cr. (Mar 2024) to 3,893.00 Cr., marking a decrease of 90.00 Cr..
- For Total Assets, as of Mar 2025, the value is 8,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,353.00 Cr. (Mar 2024) to 8,281.00 Cr., marking an increase of 928.00 Cr..
Notably, the Reserves (3,846.00 Cr.) exceed the Borrowings (554.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 442.00 | -330.00 | -238.00 | -311.00 | -351.00 | -337.00 | -510.00 | -478.00 | -607.00 | -526.00 | -552.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 |
| Inventory Days | 151 | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 |
| Days Payable | 95 | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 |
| Cash Conversion Cycle | 73 | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 |
| Working Capital Days | -13 | 18 | 0 | 23 | 37 | 27 | 24 | -11 | 5 | 2 | 14 | 16 |
| ROCE % | 29% | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| UTI Flexi Cap Fund | 5,101,646 | 1.07 | 269.29 | 5,101,646 | 2025-04-22 17:25:27 | 0% |
| Franklin India Flexi Cap Fund | 4,100,000 | 1.53 | 216.42 | 4,100,000 | 2025-04-22 17:25:27 | 0% |
| DSP ELSS Tax Saver Fund | 2,119,918 | 0.81 | 111.9 | 2,119,918 | 2025-04-22 17:25:27 | 0% |
| Franklin India Bluechip Fund - Dividend | 2,000,000 | 1.41 | 105.57 | 2,000,000 | 2025-04-22 17:25:27 | 0% |
| Franklin India Bluechip Fund - Growth | 2,000,000 | 1.41 | 105.57 | 2,000,000 | 2025-04-22 17:25:27 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 1,910,400 | 0.28 | 100.84 | 1,910,400 | 2025-04-22 17:25:27 | 0% |
| Franklin India ELSS Tax Saver Fund | 1,800,000 | 1.58 | 95.01 | 1,800,000 | 2025-04-22 17:25:27 | 0% |
| UTI Value Fund | 1,800,000 | 1.12 | 95.01 | 1,800,000 | 2025-04-22 17:25:27 | 0% |
| UTI Dividend Yield Fund | 1,700,000 | 2.54 | 89.73 | 1,700,000 | 2025-04-22 17:25:27 | 0% |
| ICICI Prudential Balanced Advantage Fund | 1,516,800 | 0.15 | 80.06 | 1,516,800 | 2025-04-22 17:25:27 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.59 | 11.46 | 10.08 | 9.50 | 9.08 |
| Diluted EPS (Rs.) | 12.56 | 11.43 | 10.05 | 9.49 | 9.08 |
| Cash EPS (Rs.) | 14.23 | 12.87 | 11.45 | 10.81 | 10.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Revenue From Operations / Share (Rs.) | 83.96 | 74.83 | 75.69 | 73.74 | 62.39 |
| PBDIT / Share (Rs.) | 18.19 | 16.81 | 15.15 | 13.79 | 13.06 |
| PBIT / Share (Rs.) | 16.81 | 15.58 | 13.95 | 12.71 | 11.98 |
| PBT / Share (Rs.) | 16.40 | 15.02 | 13.51 | 12.41 | 11.82 |
| Net Profit / Share (Rs.) | 12.85 | 11.64 | 10.25 | 9.73 | 9.31 |
| NP After MI And SOA / Share (Rs.) | 12.63 | 11.48 | 10.09 | 9.50 | 9.09 |
| PBDIT Margin (%) | 21.66 | 22.45 | 20.01 | 18.70 | 20.93 |
| PBIT Margin (%) | 20.02 | 20.82 | 18.42 | 17.24 | 19.20 |
| PBT Margin (%) | 19.53 | 20.06 | 17.85 | 16.83 | 18.94 |
| Net Profit Margin (%) | 15.30 | 15.55 | 13.53 | 13.19 | 14.92 |
| NP After MI And SOA Margin (%) | 15.04 | 15.34 | 13.33 | 12.87 | 14.56 |
| Return on Networth / Equity (%) | 40.99 | 38.64 | 34.27 | 36.58 | 36.17 |
| Return on Capital Employeed (%) | 36.90 | 40.38 | 39.82 | 45.14 | 44.20 |
| Return On Assets (%) | 19.53 | 19.95 | 18.74 | 21.17 | 21.27 |
| Total Debt / Equity (X) | 0.09 | 0.09 | 0.12 | 0.10 | 0.10 |
| Asset Turnover Ratio (%) | 1.37 | 1.34 | 1.53 | 1.50 | 1.34 |
| Current Ratio (X) | 2.07 | 1.64 | 1.57 | 1.63 | 1.66 |
| Quick Ratio (X) | 1.56 | 1.09 | 1.07 | 0.97 | 1.10 |
| Inventory Turnover Ratio (X) | 8.43 | 3.08 | 3.53 | 3.94 | 2.98 |
| Dividend Payout Ratio (NP) (%) | 27.80 | 82.98 | 44.70 | 97.55 | 82.59 |
| Dividend Payout Ratio (CP) (%) | 25.06 | 74.98 | 39.94 | 87.60 | 73.83 |
| Earning Retention Ratio (%) | 72.20 | 17.02 | 55.30 | 2.45 | 17.41 |
| Cash Earning Retention Ratio (%) | 74.94 | 25.02 | 60.06 | 12.40 | 26.17 |
| Interest Coverage Ratio (X) | 44.28 | 29.70 | 34.89 | 45.62 | 49.56 |
| Interest Coverage Ratio (Post Tax) (X) | 32.28 | 21.58 | 24.61 | 33.18 | 35.94 |
| Enterprise Value (Cr.) | 83930.05 | 63877.10 | 61757.30 | 64793.85 | 52505.50 |
| EV / Net Operating Revenue (X) | 7.75 | 6.62 | 6.33 | 6.81 | 6.52 |
| EV / EBITDA (X) | 35.76 | 29.46 | 31.61 | 36.42 | 31.16 |
| MarketCap / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| Retention Ratios (%) | 72.19 | 17.01 | 55.29 | 2.44 | 17.40 |
| Price / BV (X) | 21.15 | 16.73 | 16.29 | 19.41 | 16.38 |
| Price / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
After reviewing the key financial ratios for Marico Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has increased from 11.46 (Mar 24) to 12.59, marking an increase of 1.13.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.56. This value is within the healthy range. It has increased from 11.43 (Mar 24) to 12.56, marking an increase of 1.13.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.23. This value is within the healthy range. It has increased from 12.87 (Mar 24) to 14.23, marking an increase of 1.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.96. It has increased from 74.83 (Mar 24) to 83.96, marking an increase of 9.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.19, marking an increase of 1.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.81. This value is within the healthy range. It has increased from 15.58 (Mar 24) to 16.81, marking an increase of 1.23.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.40. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 16.40, marking an increase of 1.38.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.85. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 12.85, marking an increase of 1.21.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.63. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 12.63, marking an increase of 1.15.
- For PBDIT Margin (%), as of Mar 25, the value is 21.66. This value is within the healthy range. It has decreased from 22.45 (Mar 24) to 21.66, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 20.02. This value exceeds the healthy maximum of 20. It has decreased from 20.82 (Mar 24) to 20.02, marking a decrease of 0.80.
- For PBT Margin (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 20.06 (Mar 24) to 19.53, marking a decrease of 0.53.
- For Net Profit Margin (%), as of Mar 25, the value is 15.30. This value exceeds the healthy maximum of 10. It has decreased from 15.55 (Mar 24) to 15.30, marking a decrease of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has decreased from 15.34 (Mar 24) to 15.04, marking a decrease of 0.30.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.99. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 40.99, marking an increase of 2.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 40.38 (Mar 24) to 36.90, marking a decrease of 3.48.
- For Return On Assets (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 19.95 (Mar 24) to 19.53, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.37. It has increased from 1.34 (Mar 24) to 1.37, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 1.64 (Mar 24) to 2.07, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 1.56, marking an increase of 0.47.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.43. This value exceeds the healthy maximum of 8. It has increased from 3.08 (Mar 24) to 8.43, marking an increase of 5.35.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 27.80. This value is within the healthy range. It has decreased from 82.98 (Mar 24) to 27.80, marking a decrease of 55.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 25.06. This value is within the healthy range. It has decreased from 74.98 (Mar 24) to 25.06, marking a decrease of 49.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 72.20. This value exceeds the healthy maximum of 70. It has increased from 17.02 (Mar 24) to 72.20, marking an increase of 55.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 74.94. This value exceeds the healthy maximum of 70. It has increased from 25.02 (Mar 24) to 74.94, marking an increase of 49.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 44.28. This value is within the healthy range. It has increased from 29.70 (Mar 24) to 44.28, marking an increase of 14.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.28. This value is within the healthy range. It has increased from 21.58 (Mar 24) to 32.28, marking an increase of 10.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 83,930.05. It has increased from 63,877.10 (Mar 24) to 83,930.05, marking an increase of 20,052.95.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.75. This value exceeds the healthy maximum of 3. It has increased from 6.62 (Mar 24) to 7.75, marking an increase of 1.13.
- For EV / EBITDA (X), as of Mar 25, the value is 35.76. This value exceeds the healthy maximum of 15. It has increased from 29.46 (Mar 24) to 35.76, marking an increase of 6.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For Retention Ratios (%), as of Mar 25, the value is 72.19. This value exceeds the healthy maximum of 70. It has increased from 17.01 (Mar 24) to 72.19, marking an increase of 55.18.
- For Price / BV (X), as of Mar 25, the value is 21.15. This value exceeds the healthy maximum of 3. It has increased from 16.73 (Mar 24) to 21.15, marking an increase of 4.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Marico Ltd:
- Net Profit Margin: 15.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 36.9% (Industry Average ROCE: 14.09%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.99% (Industry Average ROE: 12.05%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 56.7 (Industry average Stock P/E: 152.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 7th Floor, Grande Palladium, 175, CST Road, Mumbai Maharashtra 400098 | investor@marico.com http://www.marico.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harsh Mariwala | Chairman & Non-Exe.Director |
| Mr. Saugata Gupta | Managing Director & CEO |
| Mr. Nikhil Khattau | Non Executive Director |
| Mr. Rishabh Mariwala | Non Executive Director |
| Mr. Rajendra Mariwala | Non Executive Director |
| Mr. Milind Barve | Lead Independent Director |
| Mr. Ananth Sankaranarayanan | Independent Director |
| Mr. Rajeev Vasudeva | Independent Director |
| Ms. Apurva Purohit | Independent Director |
| Ms. Nayantara Bali | Independent Director |
| Mr. Rajan Bharti Mittal | Independent Director |
FAQ
What is the intrinsic value of Marico Ltd?
Marico Ltd's intrinsic value (as of 29 November 2025) is 592.91 which is 18.44% lower the current market price of 727.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 94,416 Cr. market cap, FY2025-2026 high/low of 766/578, reserves of ₹3,846 Cr, and liabilities of 8,281 Cr.
What is the Market Cap of Marico Ltd?
The Market Cap of Marico Ltd is 94,416 Cr..
What is the current Stock Price of Marico Ltd as on 29 November 2025?
The current stock price of Marico Ltd as on 29 November 2025 is 727.
What is the High / Low of Marico Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Marico Ltd stocks is 766/578.
What is the Stock P/E of Marico Ltd?
The Stock P/E of Marico Ltd is 56.7.
What is the Book Value of Marico Ltd?
The Book Value of Marico Ltd is 31.2.
What is the Dividend Yield of Marico Ltd?
The Dividend Yield of Marico Ltd is 1.44 %.
What is the ROCE of Marico Ltd?
The ROCE of Marico Ltd is 45.2 %.
What is the ROE of Marico Ltd?
The ROE of Marico Ltd is 41.3 %.
What is the Face Value of Marico Ltd?
The Face Value of Marico Ltd is 1.00.